NTV Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
NTV Asset Management's PPH Position: Q3 2026 in Review
NTV Asset Management increased its VanEck Pharmaceutical ETF (PPH) stake by 3.7% in Q3 2026, buying an estimated $23.9K and bringing the position to 6,033 shares worth $661K. The position accounts for 0.06% of the portfolio, ranked #196.
NTV Asset Management first reported a position in PPH in Q2 2015 and has held it in 18 quarters since. The position peaked at $836K in Q1 2025. 116 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- NTV Asset Management held 6,033 shares of VanEck Pharmaceutical ETF worth $661K as of Q3 2026.
- NTV Asset Management bought 214 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $23.9K.
- VanEck Pharmaceutical ETF made up 0.06% of NTV Asset Management's portfolio in Q3 2026, its #196 holding.
- NTV Asset Management first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and has held it in 18 quarters since.
- NTV Asset Management's VanEck Pharmaceutical ETF position peaked at $836K in Q1 2025.
- 116 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on NTV Asset Management's 13F filing for Q3 2026, filed 23 Oct 2026.